Cortexyme

Cortexyme is a California-based biopharmaceutical company that develops disease-modifying therapeutics for the treatment of neurodegenerative and Alzheimer’s diseases.

Business Model:

Revenue: $167M

Employees: 51-200

Detailed Cortexyme Information

Geographic Data

Cortexyme headquarters map

Address: 269 East Grand Avenue

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$125M

Raised Total:

$225M

Metrics

3,040,583Website Global Rank

5,697Website Monthly Traffic

Twitter Followers

Description

Cortexyme is a California-based biopharmaceutical company that develops disease-modifying therapeutics for the treatment of neurodegenerative and Alzheimer’s diseases.

Contact Phone:
+14159105717

Contact Email:

Cortexyme went public on 5/8/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/8/2019

IPO Valuation:
$442M

Ticker Symbol:
CRTX

IPO Price:
$17/share

Amount Raised:
$75M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research